{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:00:25Z","timestamp":1792616425161,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T00:00:00Z","timestamp":1539388800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s40257-018-0394-1","type":"journal-article","created":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T04:51:58Z","timestamp":1539406318000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Association Between Psoriasis and Vitiligo: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2649-2563","authenticated-orcid":false,"given":"Hsi","family":"Yen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5699-0283","authenticated-orcid":false,"given":"Ching-Chi","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,13]]},"reference":[{"issue":"2","key":"394_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","volume":"31","author":"I Michalek","year":"2017","unstructured":"Michalek I, Loring B, John S. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(2):205\u201312.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7130","key":"394_CR2","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nature05663","volume":"445","author":"MA Lowes","year":"2007","unstructured":"Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445(7130):866\u201373.","journal-title":"Nature"},{"issue":"3","key":"394_CR3","first-page":"416","volume":"8","author":"G Damiani","year":"2018","unstructured":"Damiani G, Berti E, Pigatto P, Franchi C, Asa\u2019ad F. Benchmarking stem cells and transplantation in psoriasis. J Stem Cell Res Ther. 2018;8(3):416.","journal-title":"J Stem Cell Res Ther"},{"issue":"10","key":"394_CR4","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","volume":"51","author":"C Kr\u00fcger","year":"2012","unstructured":"Kr\u00fcger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children\/adolescents and adults. Int J Dermatol. 2012;51(10):1206\u201312.","journal-title":"Int J Dermatol"},{"issue":"3","key":"394_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","volume":"65","author":"A Alikhan","year":"2011","unstructured":"Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview: part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011;65(3):473\u201391.","journal-title":"J Am Acad Dermatol."},{"issue":"1","key":"394_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jdermsci.2011.03.002","volume":"63","author":"TF Tsai","year":"2011","unstructured":"Tsai TF, Wang TS, Hung ST, Tsai PI, Schenkel B, Zhang M, et al. Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci. 2011;63(1):40\u20136.","journal-title":"J Dermatol Sci"},{"issue":"5","key":"394_CR7","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jaad.2012.04.039","volume":"67","author":"JJ Wu","year":"2012","unstructured":"Wu JJ, Nguyen TU, Poon KYT, Herrinton LJ. The association of psoriasis with autoimmune diseases. J Am Acad Dermatol. 2012;67(5):924\u201330.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"394_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000381913","volume":"231","author":"M Augustin","year":"2015","unstructured":"Augustin M, Radtke MA, Glaeske G, Reich K, Christophers E, Schaefer I, et al. Epidemiology and comorbidity in children with psoriasis and atopic eczema. Dermatology. 2015;231(1):35\u201340.","journal-title":"Dermatology"},{"issue":"10","key":"394_CR9","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.2340\/00015555-2743","volume":"97","author":"C Blegvad","year":"2017","unstructured":"Blegvad C, Egeberg A, Tind Nielsen TE, Gislason GH, Zachariae C, Nybo Andersen AM, et al. Autoimmune disease in children and adolescents with psoriasis: A cross-sectional study in Denmark. Acta Derm Venereol. 2017;97(10):1225\u20139.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"394_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/jdv.13813","volume":"31","author":"MA Radtke","year":"2017","unstructured":"Radtke MA, Sch\u00e4fer I, Glaeske G, Jacobi A, Augustin M. Prevalence and comorbidities in adults with psoriasis compared to atopic eczema. J Eur Acad Dermatol Venereol. 2017;31(1):151\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"394_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2147\/CCID.S142819","volume":"10","author":"KE Sharquie","year":"2017","unstructured":"Sharquie KE, Salman HA, Yaseen AK. Psoriasis and vitiligo are close relatives. Clin Cosmet Investig Dermatol. 2017;10:341\u20135.","journal-title":"Clin Cosmet Investig Dermatol."},{"issue":"5","key":"394_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00403-017-1741-4","volume":"309","author":"N Zander","year":"2017","unstructured":"Zander N, Sch\u00e4fer I, Radtke M, Jacobi A, Heigel H, Augustin M. Dermatological comorbidity in psoriasis: results from a large-scale cohort of employees. Arch Dermatol Res. 2017;309(5):349\u201356.","journal-title":"Arch Dermatol Res"},{"issue":"7","key":"394_CR13","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/jdv.12870","volume":"29","author":"YT Chen","year":"2015","unstructured":"Chen YT, Chen YJ, Hwang CY, Lin MW, Chen TJ, Chen CC, et al. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan. J Eur Acad Dermatol Venereol. 2015;29(7):1362\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"394_CR14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3349\/ymj.2015.56.3.719","volume":"56","author":"H Lee","year":"2015","unstructured":"Lee H, Lee MH, Lee DY, Kang HY, Kim KH, Choi GS, et al. Prevalence of vitiligo and associated comorbidities in Korea. Yonsei Med J. 2015;56(3):719\u201325.","journal-title":"Yonsei Med J"},{"issue":"4","key":"394_CR15","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/bjd.14640","volume":"175","author":"HE Teulings","year":"2016","unstructured":"Teulings HE, Ceylan E, Overkamp M, Vrijman C, Bos JD, Nijsten TE, et al. Nonsegmental vitiligo disease duration and female sex are associated with comorbidity and disease extent: a retrospective analysis in 1307 patients aged\u2009\u2265\u200950 years. Br J Dermatol. 2016;175(4):821\u20134.","journal-title":"Br J Dermatol"},{"issue":"5","key":"394_CR16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1185\/030079906X104641","volume":"22","author":"D Robinson Jr","year":"2006","unstructured":"Robinson D Jr, Hackett M, Wong J, Kimball AB, Cohen R, Bala M, et al. Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001\u20132002. Curr Med Res Opin. 2006;22(5):989\u20131000.","journal-title":"Curr Med Res Opin"},{"key":"394_CR17","first-page":"7","volume":"6","author":"N Ayala-Font\u00e1nez","year":"2016","unstructured":"Ayala-Font\u00e1nez N, Soler DC, McCormick TS. Current knowledge on psoriasis and autoimmune diseases. Psoriasis (Auckl). 2016;6:7\u201332.","journal-title":"Psoriasis (Auckl)."},{"issue":"15","key":"394_CR18","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008\u201312.","journal-title":"JAMA"},{"key":"394_CR19","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2006. \n                    http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\n                    \n                  . Accessed 6 Feb 2018."},{"issue":"3","key":"394_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"issue":"11","key":"394_CR21","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"J Higgins","year":"2002","unstructured":"Higgins J, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"7414","key":"394_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"7109","key":"394_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"5","key":"394_CR24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/120347541201600505","volume":"16","author":"M Sawchuk","year":"2012","unstructured":"Sawchuk M, Spano F, Loo WJ, Guenther L. The coexistence of psoriasis and vitiligo: a review. J Cutan Med Surg. 2012;16(5):300\u20135.","journal-title":"J Cutan Med Surg."},{"issue":"1","key":"394_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jaad.2003.12.014","volume":"51","author":"K Sandhu","year":"2004","unstructured":"Sandhu K, Kaur I, Kumar B. Psoriasis and vitiligo. J Am Acad Dermatol. 2004;51(1):149\u201350.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"394_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrg2489","volume":"10","author":"A Zhernakova","year":"2009","unstructured":"Zhernakova A, Van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet. 2009;10(1):43\u201355.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"394_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1369\/jhc.6A7101.2006","volume":"55","author":"JA Kummer","year":"2007","unstructured":"Kummer JA, Broekhuizen R, Everett H, Agostini L, Kuijk L, Martinon F, et al. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem. 2007;55(5):443\u201352.","journal-title":"J Histochem Cytochem"},{"issue":"3","key":"394_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00281-007-0079-y","volume":"29","author":"F Martinon","year":"2007","unstructured":"Martinon F, Gaide O, P\u00e9trilli V, Mayor A, Tschopp J. NALP inflammasomes: a central role in innate immunity. Semin Immunopathol. 2007;29(3):213\u201329.","journal-title":"Semin Immunopathol."},{"issue":"12","key":"394_CR29","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/NEJMoa061592","volume":"356","author":"Y Jin","year":"2007","unstructured":"Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med. 2007;356(12):1216\u201325.","journal-title":"N Engl J Med"},{"issue":"12","key":"394_CR30","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/exd.12049","volume":"21","author":"M Carlstr\u00f6m","year":"2012","unstructured":"Carlstr\u00f6m M, Ekman AK, Petersson S, S\u00f6derkvist P, Enerb\u00e4ck C. Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility. Exp Dermatol. 2012;21(12):932\u20137.","journal-title":"Exp Dermatol"},{"issue":"12","key":"394_CR31","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1038\/sj.jid.5700922","volume":"127","author":"C Johansen","year":"2007","unstructured":"Johansen C, Moeller K, Kragballe K, Iversen L. The activity of caspase-1 is increased in lesional psoriatic epidermis. J Invest Dermatol. 2007;127(12):2857\u201364.","journal-title":"J Invest Dermatol."},{"issue":"3","key":"394_CR32","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/jid.2010.370","volume":"131","author":"ML Salskov-Iversen","year":"2011","unstructured":"Salskov-Iversen ML, Johansen C, Kragballe K, Iversen L. Caspase-5 expression is upregulated in lesional psoriatic skin. J Invest Dermatol. 2011;131(3):670\u20136.","journal-title":"J Invest Dermatol."},{"issue":"4","key":"394_CR33","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/bjd.12691","volume":"170","author":"J Marie","year":"2014","unstructured":"Marie J, Kovacs D, Pain C, Jouary T, Cota C, Vergier B, et al. Inflammasome activation and vitiligo\/nonsegmental vitiligo progression. Br J Dermatol. 2014;170(4):816\u201323.","journal-title":"Br J Dermatol"},{"issue":"11","key":"394_CR34","doi-asserted-by":"publisher","first-page":"e23089","DOI":"10.1371\/journal.pone.0023089","volume":"6","author":"K-J Zhu","year":"2011","unstructured":"Zhu K-J, Lv Y-M, Yin X-Y, Wang Z-X, Sun L-D, He S-M, et al. Psoriasis regression analysis of MHC loci identifies shared genetic variants with vitiligo. PLoS One. 2011;6(11):e23089.","journal-title":"PLoS One"},{"issue":"9583","key":"394_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263\u201371.","journal-title":"Lancet"},{"issue":"3","key":"394_CR36","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1365-2133.2009.09217.x","volume":"161","author":"Z Taher","year":"2009","unstructured":"Taher Z, Lauzon G, Maguiness S, Dytoc M. Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus. Br J Dermatol. 2009;161(3):654\u20139.","journal-title":"Br J Dermatol"},{"issue":"6","key":"394_CR37","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/jid.2009.59","volume":"129","author":"A Cesare Di","year":"2009","unstructured":"Di Cesare A, Di Meglio P, Nestle FO. The IL-23\/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 2009;129(6):1339\u201350.","journal-title":"J Invest Dermatol."},{"issue":"4","key":"394_CR38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.autrev.2016.01.004","volume":"15","author":"RK Singh","year":"2016","unstructured":"Singh RK, Lee KM, Vujkovic-Cvijin I, Ucmak D, Farahnik B, Abrouk M, et al. The role of IL-17 in vitiligo: a review. Autoimmun Rev. 2016;15(4):397\u2013404.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"394_CR39","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jaad.2008.09.048","volume":"60","author":"PY Basak","year":"2009","unstructured":"Basak PY, Adiloglu AK, Ceyhan AM, Tas T, Akkaya VB. The role of helper and regulatory T cells in the pathogenesis of vitiligo. J Am Acad Dermatol. 2009;60(2):256\u201360.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"394_CR40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1365-2230.2010.03972.x","volume":"36","author":"D Bassiouny","year":"2011","unstructured":"Bassiouny D, Shaker O. Role of interleukin-17 in the pathogenesis of vitiligo. Clin Exp Dermatol. 2011;36(3):292\u20137.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"394_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000246208","volume":"193","author":"H Simsek","year":"1996","unstructured":"Simsek H, Savas C, Akkiz H, Telatar H. Interferon-induced vitiligo in a patient with chronic viral hepatitis C infection. Dermatology. 1996;193(1):65\u20136.","journal-title":"Dermatology"},{"issue":"7","key":"394_CR42","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/j.1365-4632.2009.04443.x","volume":"49","author":"I Hamadah","year":"2010","unstructured":"Hamadah I, Binamer Y, Sanai FM, Abdo AA, Alajlan A. Interferon-induced vitiligo in hepatitis C patients: a case series. Int J Dermatol. 2010;49(7):829\u201333.","journal-title":"Int J Dermatol"},{"issue":"6","key":"394_CR43","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1468-3083.2012.04582.x","volume":"27","author":"M Afshar","year":"2013","unstructured":"Afshar M, Martinez A, Gallo R, Hata T. Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases. J Eur Acad Dermatol Venereol. 2013;27(6):771\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"394_CR44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0168-8278(96)80184-X","volume":"24","author":"G Fattovich","year":"1996","unstructured":"Fattovich G, Giustina G, Favarato S, Ruol A. A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol. 1996;24(1):38\u201347.","journal-title":"J Hepatol"},{"issue":"5","key":"394_CR45","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.0736-8046.2004.21512.x","volume":"21","author":"D Se\u00e7kin","year":"2004","unstructured":"Se\u00e7kin D, Durusoy \u00c7, \u015eahin S. Concomitant vitiligo and psoriasis in a patient treated with interferon alfa-2a for chronic hepatitis B infection. Pediatr Dermatol. 2004;21(5):577\u20139.","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"394_CR46","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.coi.2008.06.008","volume":"20","author":"M Gilliet","year":"2008","unstructured":"Gilliet M, Lande R. Antimicrobial peptides and self-DNA in autoimmune skin inflammation. Curr Opin Immunol. 2008;20(4):401\u20137.","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"394_CR47","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/pcmr.12219","volume":"27","author":"A Bertolotti","year":"2014","unstructured":"Bertolotti A, Boniface K, Vergier B, Mossalayi D, Taieb A, Ezzedine K, et al. Type I interferon signature in the initiation of the immune response in vitiligo. Pigment Cell Melanoma Res. 2014;27(3):398\u2013407.","journal-title":"Pigment Cell Melanoma Res."},{"issue":"4","key":"394_CR48","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","volume":"76","author":"W Damsky","year":"2017","unstructured":"Damsky W, King BA. JAK inhibitors in dermatology: the promise of a new drug class. J Am Acad Dermatol. 2017;76(4):736\u201344.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"394_CR49","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/jdv.14695","volume":"32","author":"CM Kuo","year":"2018","unstructured":"Kuo CM, Tung TH, Wang SH, Chi CC. Efficacy and safety of tofacitinib for moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials. J Eur Acad Dermatol Venereol. 2018;32(3):355\u201362.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"394_CR50","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1111\/bjd.13988","volume":"173","author":"M Malerba","year":"2015","unstructured":"Malerba M, Damiani G, Radaeli A, Ragnoli B, Olivini A, Calzavara-Pinton P. Narrowband ultraviolet B phototherapy in psoriasis reduces proinflammatory cytokine levels and improves vitiligo and neutrophilic asthma. Br J Dermatol. 2015;173(6):1544\u20135.","journal-title":"Br J Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-018-0394-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-018-0394-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-018-0394-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T22:05:08Z","timestamp":1570917908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-018-0394-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,13]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["394"],"URL":"https:\/\/doi.org\/10.1007\/s40257-018-0394-1","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,13]]},"assertion":[{"value":"13 October 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No funding was received for the conduct of this study or the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Hsi Yen and Ching-Chi Chi have no conflicts of interest directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}